We also observed that ATO treatment induced SIRPα expression in APL cells in a time-dependent manner and abrogation of SIRPα induction prevented APL cell apoptosis and left the β-catenin signaling pathway unperturbed by the ATO treatment. The gene discussed is SIRPA; the disease is acute promyelocytic leukemia.